Status:
UNKNOWN
Comparing Analgesic Effects of Wound Infiltration Using Bupivacaine, Tramadol, and Tramadol Plus Bupivacaine
Lead Sponsor:
Wollo University
Conditions:
Pain, Postoperative
Eligibility:
FEMALE
18-35 years
Phase:
PHASE4
Brief Summary
The goal of this study's clinical trial is to compare in post-operative analgesic effectiveness of wound infiltration using bupivacaine, tramadol, and tramadol plus bupivacaine in patients undergoing ...
Detailed Description
Source Population: All parturients who are scheduled for elective cesarean delivery under spinal anesthesia at Dessie Comprehensive Specialized Hospital Sample size determination: since there is no p...
Eligibility Criteria
Inclusion
- Women age between 18 and 35
- ASA risk class I-II
Exclusion
- \- Chronic pain diagnosis
- ASA above II
- Comorbidities (Anemia, DM, HTN, Arthritis)
- Known allergy to bupivacaine, tramadol
- History of alcohol, opiate, or other drug abuse
- Use of preoperative anti-pain
Key Trial Info
Start Date :
November 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 2 2024
Estimated Enrollment :
163 Patients enrolled
Trial Details
Trial ID
NCT06076707
Start Date
November 30 2023
End Date
June 2 2024
Last Update
November 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dessie comprehensive specilized hospital
Dessie, Amhara, Ethiopia, 801103